OMNIPAQUE 350mg I/ml 350mg I /ml solution for injection GE HEALTHCARE
iohexol Indicated for: diagnostic imaging contrast enhancement
letter O · page 22
iohexol Indicated for: diagnostic imaging contrast enhancement
gadodiamide Indicated for: diagnostic imaging contrast enhancement
V08CA03 Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media
gadodiamide Indicated for: diagnostic imaging contrast enhancement
V08CA03 Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media
somatropin Indicated for: growth hormone deficiency
somatropin Indicated for: growth hormone deficiency
somatropin Indicated for: growth hormone deficiency
somatropin Indicated for: growth hormone deficiency
somatropin Indicated for: growth hormone deficiency
somatropin Indicated for: growth hormone deficiency
somatropin Indicated for: growth hormone deficiency
omeprazole Indicated for: peptic ulcer; gastroesophageal reflux
mirikizumab Indicated for: ulcerative colitis
mirikizumab Indicated for: ulcerative colitis
mirikizumab Indicated for: ulcerative colitis
mirikizumab Indicated for: ulcerative colitis
omeprazole Indicated for: peptic ulcer; gastroesophageal reflux
indacaterol Indicated for: chronic obstructive pulmonary disease
R03AC18 Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists
indacaterol Indicated for: chronic obstructive pulmonary disease
R03AC18 Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists
asparaginase Indicated for: leukemia
L01XX02 Antineoplastic and immunomodulating agents | Other antineoplastic agents
pegaspargase Indicated for: cancer
L01XX24 Antineoplastic and immunomodulating agents | Other antineoplastic agents